Skip to main content
. 2021 Feb 9;11:3363. doi: 10.1038/s41598-021-83082-7

Figure 1.

Figure 1

Mcl-1 deficiency enhanced DEN-induced liver tumor development. At the age of 2 weeks, male Mcl-1fl/fl and Mcl-1Δhep mice were intraperitonially injected with PBS or DEN (20 mg/kg BW), and their livers were harvested after 4 or 6 months. (A,B) Representative images of the livers of PBS- or DEN-treated male Mcl-1 fl/fl and Mcl-1Δhep mice at the ages of 4 months (A) and 6 months (B). (C,D) Incidence rate of macroscopic (C) or microscopic (D) tumors at the age of 4 and 6 months (n ≥ 8 per group, chi-squared test). (E) Representative H&E staining images of liver sections from the DEN-treated male 6-month-old Mcl-1fl/fl and 6-month-old Mcl-1Δhep mice. The scale bar is 100 µm. (F) Ratio of liver weight to body weight (mean ± SEM, Mann–Whitney test). (G) Maximum tumor size (diameters by caliper) at the age of 6 months (mean ± SEM, Mann–Whitney test). (H) Mutation rate of B-Raf V637E in liver tumors (chi-squared test, *p < 0.05).